Northland gives K2M "Outperform" rating — 5 things to know

Spinal Tech

A new group of analysts initiated coverage of K2M shares, according to a WKRB News & Analysis report.

Here are five things to know:

 

1. Northland Securities will now cover K2M.
2. The company issued an "outperform" rating.
3. The price objective on the stock is $31.
4. Barclays also raised K2M's price target from $27 to $28.
5. K2M's market cap is $988.2 million.

 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers